[PDF] Top 20 Tema 10. La Actuación Del Celador en Las
Has 10000 "Tema 10. La Actuación Del Celador en Las" found on our website. Below are the top 20 most common "Tema 10. La Actuación Del Celador en Las".
Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation
... Unadjusted survival probabilities were estimated using the Kaplan and Meier method and compared using the log-rank ...on survival, we performed a landmark analysis, which divided patients according ... See full document
5
Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
... for hematopoietic cell transplantation (HCT) in acute myelogenous leukemia (AML) remains ...AML patients treated with oral busulfan (1 mg/kg every 6 hours for 4 days) and ... See full document
18
Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission
... and leukemia relapse after allo-HSCT has been an area of scientific interest for several ...in patients with ALL, lymphoma, CML, or MDS ...superior leukemia-free survival ...AML ... See full document
118
<p>High expression of dedicator of cytokinesis 1 adversely influences the prognosis of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation</p>
... overall survival (OS), which was de fi ned as the time from diagnosis to death or was censored at the last ...the survival curves were ...between survival distribu- ...prognostic factors. The ... See full document
131
Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.
... adult leukemia and causes constitutive tyrosine kinase ...AML patients prior to allo-HCT with sorafenib ...the patients had remissions followed by allo-HCT ...includes patients over 60 years ... See full document
10
Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia
... lymphoid leukemia; allo- HSCT: Allogeneic hematopoietic stem cell transplantation; AML: Acute myeloid leukemia; ANC: Absolute neutrophil count; BM: Bone marrow; Bu: Busulfan; ... See full document
6
Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapse after Initial Allogeneic Transplant in Childhood Leukemia - A Single Center Experience
... overall survival rate of these patients was ...the survival rate after the first line Hsct for childhood ...died patients was relapse in 10, MoF in 2, bo in 1 and GVHd in ...these ... See full document
8
Original Article Survival disparities in patients with relapsed core-binding factor acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
... myeloid leukemia (CBF-AML) has traditionally been associated with favorable prognosis ...of allogeneic hematopoietic stem cell transplantation (HSCT) in first remission (CR 1 ) ... See full document
17
An addition of medium dose ATG to conditioning regimens favours the long term survival of patients with allogeneic hematopoietic stem cell transplantation
... 201 patients with hematologic malignancies were randomized to receive cyclosporine A (CyA) and MTX with or without additional ATG-fresenius ...stem cell source was peripheral blood (n = 164; 82%) or bone ... See full document
34
Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China
... lymphoblastic leukemia (ALL) express the onco- genic BCR-ABL protein, which results from a 9;22 chromosomal translocation known as the Philadelphia (Ph) chromosome ...complete remission (CR) than ... See full document
12
Isolated granulocytic sarcoma of the nasopharynx: a case report and review of the literature
... of cell-surface markers (cluster of differentiation [CD]56, CD2, CD4, and CD7), and the French–American–British (FAB) classification M2, M4, and M5 leukemia ...risk factors include poor nutritional ... See full document
13
Memory T cells skew toward terminal differentiation in the CD8+ T cell population in patients with acute myeloid leukemia
... marrow (BM) from patients with AML and those with AML in complete remission (AML-CR) by multicolor flow cytometry. The gating strategy used in this study followed a published protocol [7]. The CD4+ and CD8+ ... See full document
21
Outcome of match related allogeneic stem cell transplantation procedures performed from 2004 till 2011
... myeloid leukemia in n = 11 patients (Figure ...blastic leukemia, n = 4 were positive for Philadelphia chromosome, n = 3 had disease ...Three patients with acute myeloid leukemia (AML) ... See full document
7
Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemia
... of patients with relatively poorer prognosis, the two-year estimated OS and RFS rate were significantly worse in patients with D5-PBCR ...intermediate-risk patients with low D5-PBCR may be ... See full document
7
DNA methylation dynamic of bone marrow hematopoietic stem cells after allogeneic transplantation
... Remarkably, at 60 days post HSCT, CD34 + cells mainly re-established the same gene methylation levels as donor HSPCs, except for a gene pool that remained differently methylated up to 365 days. These genes encoding for ... See full document
9
Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma
... years) patients with B cell NHL, undergoing their first RIC or non- myeloablative conditioning (NMA) allo-HCT between 2008 and ...B cell lymphoma (DLBCL), follicular lymphoma (FL), mantle cell ... See full document
6
Early myeloid-derived suppressor cells (HLA-DR−/lowCD33+CD16−) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT
... blood cell was detected from peripheral blood samples of mice at 7 days, 14 days, and 21 days after ...for survival, weight, and acute GVHD score three times a ... See full document
23
Asymmetric Bone Marrow Involvement in Patients with Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Two Case Reports and Literature Review
... However, on day +128, the blast percentage was 0% in the right (Figure 1). On day +133, a bone marrow biopsy from bilateral posterior iliac crests showed that the left bone marrow was replaced with lymphoblasts and the ... See full document
54
Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta analysis with trial sequential analysis
... We evaluated the exposure–response relationship be- tween posaconazole plasma concentration and clinical efficacy for IFIs prevention. When the plasmas were measured at different sampling time, we chose the re- sults ... See full document
9
Test of long-term uterine survival after allogeneic transplantation in rabbits
... attempts to characterize the optimal surgical method which would provide the uterine graft with a satisfac- tory blood supply. Auto- and/or syngeneic-UTn animal models are commonly used as they rather help- fully ... See full document
14
Related subjects